Green day on Wednesday for Fulcrum Therapeutics, Inc.
(Updated on Dec 08, 2021)
Sell candidate since 2021-10-18 Loss -31.73% PDF
The Fulcrum Therapeutics, Inc. stock price gained 2.48% on the last trading day (Wednesday, 8th Dec 2021), rising from $15.35 to $15.73. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 9.08% from a day low at $14.76 to a day high of $16.10. The price has risen in 6 of the last 10 days and is up by 4.8% over the past 2 weeks. Volume fell on the last day by -214 thousand shares and in total, 221 thousand shares were bought and sold for approximately $3.48 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -47.79% during the next 3 months and, with a 90% probability hold a price between $6.63 and $9.39 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, December 01, 2021, and so far it has risen 12.36%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Fulcrum Therapeutics, Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $18.70. On a fall, the stock will find some support from the short-term average at $14.68. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss
Fulcrum Therapeutics, Inc. finds support from accumulated volume at $15.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.34 between high and low, or 9.08%. For the last week, the stock has had a daily average volatility of 11.51%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Fulcrum Therapeutics, Inc. stock A Buy?
Fulcrum Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.423
Predicted Opening Price for Fulcrum Therapeutics, Inc. of Thursday, December 9, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price December 9, 2021||Current price|
Remember To Visit Our YouTube Channel
On Aug 17, 2021 "HC Wainwright" gave "$20.00 - $40.00" rating for FULC. The price target was changed from $21.74 to 5.2%.
FULC Insider Trading
|Nov 10, 2021||Sell||1 000 000||Levin Mark J||Common Stock|
|Nov 10, 2021||Sell||1 000 000||Third Rock Ventures Iii, L.p.||Common Stock|
|Sep 22, 2021||Sell||1 000 000||Levin Mark J||Common Stock|
|Sep 22, 2021||Sell||1 000 000||Third Rock Ventures Iii, L.p.||Common Stock|
|Aug 11, 2021||Buy||28 000||Stuart Bryan||Common Stock|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.